Consistent with the notion that CEP55 is a target of FOXM1B, our bioinformatics analysis of published microarray data (GEO Accession: GDS1477) in FOXM1B-knockdown (by siRNA) breast cancer cells [15] showed significant downregulation of CEP55 expression (Supplemental Fig. S5). Here, CEP55 is linked to breast carcinoma.